NLRP7 | Novel Genes for female Reproductive Failure | Novel genes for fetal loss
NLRP7

Novel Genes for female Reproductive Failure
In collaboration with several clinicians from various countries and with Dr. Jacek Majewski鈥檚 group, we have identified biallelic deleterious mutations in nine genes, MEI1, TOP6BL, REC114, FOXL2, KASH5, MAJIN, SYCP2, HFM1, and MEIOB, in patients with androgenetic hydatidiform moles. Some of these patients had recurrent androgenetic moles and others had only one mole with miscarriages and/or infertility, which highlight the roles of these genes in various forms of reproductive failure. In addition, five of these genes have been shown to be responsible for premature ovarian failure, which links molar pregnancies to ovarian ageing. These findings explain the increased frequency of moles with advanced maternal age, which is the strongest risk factor for common sporadic androgenetic HM, affecting 1 in every 600 pregnancies.
With the collaboration with Dr. Teruko Taketo, we investigated the mechanisms of androgenetic mole formation in Mei1-/- and Hfm1-/- females and found that some of their oocytes lose all their chromosomes with the entire spindle into the first polar body. The occurrence of the same mechanism in two mouse models argues in favor of its plausibility at the origin of androgenetic mole formation in humans.
Novel genes for fetal loss
We are also working on the identification of more genes causing recurrent hydatidiform moles, miscarriages, and infertility, with the collaboration of many clinicians. To achieve this goal, we recruit patients with any of the following conditions:
- at least two molar pregnancies (all histological and genotypic types),
- at least five miscarriages and no live birth,
- women with at least 5 years of infertility and no live birth.
If you had had any of the above conditions and you wish to participate in our study, please contact us at rrw [at] muhc.mcgill.ca.